Complexin-1/2过表达重组载体对阿尔茨海默病小鼠记忆损伤的实验研究

张艳玲; 刘建军; 许华; 杨细飞

doi:10.13418/j.issn.1001-165x.2016.02.015

中国临床解剖学杂志 ›› 2016, Vol. 34 ›› Issue (2) : 191-197. DOI: 10.13418/j.issn.1001-165x.2016.02.015

实验研究

Complexin-1/2过表达重组载体对阿尔茨海默病小鼠记忆损伤的实验研究

张艳玲^1,2，　刘建军²，　许华¹，　杨细飞²

作者信息 +

Construction of adeno-associated virus over-expressing vector of complexin-1/2 gene and overexpres -sion of complexin-1/2 on spatial memory impairment in mice of Alzheimer’s disease

ZHANG Yan-ling¹, LIU Jian-jun², XU Hua¹, YANG Xi-fei²

Author information +

文章历史 +

摘要

目的　构建Complexin-1/2（CPLX-1/2）基因的重组腺相关病毒过表达载体pAAV- CPLX-1/2并研究其在阿尔茨海默病记忆损伤中的作用。方法　将用Oligo 7软件对Genbank上小鼠CPLX-1/2 mRNA的CDS两端序列进行分析，合成CPLX-1/2基因，构建过表达载体并转化至大肠杆菌Top10；选取正确的克隆进行PCR和测序鉴定。重组腺相关病毒载体测序正确后，转染AAV293细胞，包装腺相关病毒。将重组腺相关病毒经脑立体定位注射到三转基因阿尔茨海默病(3XTg-AD)小鼠海马CA3区，经免疫组化和Western-Blot检测CPLX-1/2蛋白表达情况,水迷宫检测CPLX-1/2过表达对3XTg-AD小鼠记忆的影响。结果　PCR及测序结果表明成功构建了含小鼠CPLX-1/2基因的重组腺相关病毒表达载体。CPLX-1/2在海马CA3表达显著增加。CPLX-1/2过表达显著改善3XTg-AD小鼠的记忆损伤。结论　本研究成功构建了CPLX-1/2重组腺相关病毒过表达载体并在整体动物水平成功高效表达； CPLX-1/2过表达可显著改善3XTg-AD小鼠空间记忆的损伤。为在整体动物水平深入研究CPLX-1/2的功能提供了新的手段；研究结果提示CPLX-1/2可能作为AD记忆损伤治疗的关键靶点。

Abstract

Objective　To construct recombinant adeno-associated virus over-expressing vector of complexin-1/2 (CPLX-1/2) and investigate the effects of overexpression of CPLX-1/2 on spatial memory impairment in Alzheimer’s Disease.　Methods 　The CPLX-1/2 gene sequences of mice reported in Genbank were analyzed by Oligo software, and the CPLX-1/2 gene was synthesized. The overexpressing vector was constructed and transfected into Escherichia coli TOP 10. Purified plasmids from the positive clones was confirmed by PCR and sequencing. The AAV293 cells were transfected by the recombinant adeno-associated virus vector to achieve the adeno-associated virus packaging production. The recombinant adeno-associated virus vector was injected into hippocampus of 3XTg-AD mice using a stereotaxic instrument guided by a computer and a motorized nanoinjector. The expression of CPLX-1/2 in hippocampus was detected by Western-blot and immunofluorescence; Morris water maze was performed to measure the change of spatial memory impairment in 3XTg-AD mice. 　Results　The PCR and sequencing confirmed that the recombinant adeno-associated virus vector was successfully constructed. Injection of the overexpessing vector led to significantly increased expression of CPLX-1/2 in hippocampus, and significantly improved the spatial memory impairment in 3XTg-AD mice.　Conclusion　The adeno-associated virus overexpressing vector of CPLX-1/2 gene was successfully constructed, and highly expressed in hippocampus of 3XTg-AD mice. The expression of CPLX-1/2 gene in hippocampus significantly improved spatial memory impairment in 3XTg-AD mice. This study provides a new approach to further study the function of CPLX-1/2 at in vivo levels. These findings suggest that CPLX-1/2 may serve as key therapeutic targets for AD.

导出引用

张艳玲,刘建军,许华,杨细飞. Complexin-1/2过表达重组载体对阿尔茨海默病小鼠记忆损伤的实验研究[J]. 中国临床解剖学杂志. 2016, 34(2): 191-197 https://doi.org/10.13418/j.issn.1001-165x.2016.02.015

ZHANG Yan-ling, LIU Jian-jun, XU Hua, YANG Xi-fei. Construction of adeno-associated virus over-expressing vector of complexin-1/2 gene and overexpres -sion of complexin-1/2 on spatial memory impairment in mice of Alzheimer’s disease[J]. Chinese Journal of Clinical Anatomy. 2016, 34(2): 191-197 https://doi.org/10.13418/j.issn.1001-165x.2016.02.015

参考文献

[1] Tokumaru H, Umayahara K, Pellegrini LL, et al. SNARE complex oligomerizationby synaphin/complexin is essential for synaptic vesicle exocytosis [J]. Cell, 2001,104(3):421-432.
[2] Mcmahon HT, Missler M, Li C, et al. Complexins: cytosolic proteins that regulate SNAP receptor function[J]. Cell,1995,83(1):111-119.
[3] Tannenberg RK, Scott HL, Tannenberg AE, et al. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4[J]. Neurochem Int, 2006, 49(7):631-639.
[4] Yu J, Luo X, Xu H, et al. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis[J]. J Alzheimers Dis, 2015, 44(2):455-469.
[5] Nasehi M, Kafi F, Zarrindast MR. Differential mechanisms of opioidergic and dopaminergic systems of the ventral hippocampus (CA(3)) in anxiolytic-like behaviors induced by cholestasis in mice[J]. Eur J Pharmacol, 2013, 714(1-3): 352-358.
[6] 郎尉雅, 张海燕, 刘忠锦. 电针对SAMP8小鼠行为学及APP mRNA和BACE-1 mRNA影响[J]. 中国临床解剖学杂志, 2015, 35 (5): 563-567.
[7] Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory[J]. Nat Protoc, 2006, 1(2):848-858.
[8] Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease[J]. Lancet, 2006, 368(9533): 387-403.
[9] Cummings JL. Alzheimer's disease: from molecular biology to neuropsychiatry[J]. Semin Clin Neuropsychiatry, 2003, 8(1): 31-36.
[10]Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction[J]. Neuron, 2003, 39(3): 409-421.
[11]Giraudo CG, Eng WS, Melia TJ, et al. A clamping mechanism involved in SNARE-dependent exocytosis[J]. Science, 2006, 313(5787):676-680.
[12] Tang J, Maximov A, Shin OH, et al. A complexin/synaptotagmin 1 switch controls fast synaptic vesicle exocytosis[J]. Cell, 2006, 126(6):1175-1187.
[13] Ahmad M, Polepalli JS, Goswami D, et al. Postsynaptic complexin controls AMPA receptor exocytosis during LTP[J]. Neuron, 2012, 73(2):260-267.
[14] Sawada K, Barr AM, Nakamura M, et al. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia[J]. Arch Gen Psychiatry, 2005, 62(3): 263-272.
[15] Mccown TJ. Adeno-associated virus (AAV) vectors in the CNS[J]. Curr Gene Ther, 2005, 5(3): 333-338.